Amarin | 营业费用



Operating Expenses 更改 日
AbbVie USD 16.59B 5.96B 2024-12
Alnylam Pharmaceuticals USD 698.32M 120.5M 2024-12
Amarin USD 67.47M 549K 2024-09
AstraZeneca USD 12.86B 2.06B 2024-12
DBV Technologies USD 31.4M 3.6M 2024-09
GlaxoSmithKline GBP 7.42B 402M 2024-12
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Ionis Pharmaceuticals USD 337.4M 54.93M 2024-12
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Novartis USD 11.28B 1.73B 2024-12



Amarin 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2025.